Cannon CP. Elderly Patients with Acute Coronary Syndromes: Higher Risk and Greater Benefit from Antithrombotic and Interventional Therapies. Am J Geriatr Cardiol. 2000 Oct;9(5):265-270. doi: 10.1111/j.1076-7460.2000.80049.x.
McKay CR, Rich MW, Vlietstra RE, Kitzman DW, Fleg JL, Krumholz HM, Lakatta EG, Cooke JP, Cannon CP, Ezekowitz MD, Frohlich ED, Jalife J, Kass DA, Kottke BA, Muller JE, Saltin B, Shen WK, Somers VK. Executive Summary: Pivotal Research in Cardiovascular Syndromes in the Elderly. Am J Geriatr Cardiol. 2000 Oct;9(5):243-250. doi: 10.1111/j.1076-7460.2000.89991.x.
Paulo Filho W, Ribeiro JE, Pinto DS. Safety and efficacy of Eupatorium laevigatum paste as therapy for buccal aphthae: randomized, double-blind comparison with triamcinolone 0.1% orabase. Adv Ther. 2000 Nov-Dec;17(6):272-81. doi: 10.1007/BF02850010.
Januzzi JL Jr, Jang IK. Fundamental concepts in the pathobiology of heparin-induced thrombocytopenia. J Thromb Thrombolysis. 2000 Nov;10 Suppl 1:7-11. doi: 10.1023/a:1027320917297.
D’Agostino R, Machin D, Palmer C. Preface. Stat Med. 2000 Dec 30;19(24):3307-3308. doi: 10.1002/1097-0258(20001230)19:24<3307::aid-sim863>3.0.co;2-h.
Gibson CM, Anshelevich M, Murphy S, Luu L, Hynes C, Kliris J, Kermgard S, Otten MH, Antman EM, Cannon CP, Braunwald E; Thrombolysis in Myocardial Infarction. Impact of injections during diagnostic coronary arteriography on coronary patency in the setting of acute myocardial infarction from the TIMI trials. Thrombolysis In Myocardial Infarction. Am J Cardiol. 2000 Dec 15;86(12):1378-9, A5. doi: 10.1016/s0002-9149(00)01248-0.
Gibson CM, Goel M, Murphy SA, Dotani I, Marble SJ, Deckelbaum LI, Dodge JT, King SB 3rd; Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis. Global impairment of coronary blood flow in the setting of acute coronary syndromes (a RESTORE substudy). Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis. Am J Cardiol. 2000 Dec 15;86(12):1375-7, A5. doi: 10.1016/s0002-9149(00)01247-9.
Cannon CP. Exploring the issues of appropriate dosing in the treatment of acute myocardial infarction: potential benefits of bolus fibrinolytic agents. Am Heart J. 2000 Dec;140(6 Suppl):S154-60. doi: 10.1067/mhj.2000.111605.
Morrow DA, Antman EM, Tanasijevic M, Rifai N, de Lemos JA, McCabe CH, Cannon CP, Braunwald E. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. J Am Coll Cardiol. 2000 Nov 15;36(6):1812-7. doi: 10.1016/s0735-1097(00)00942-6.
Turchin A, Lehmann CU. Active Learning Centre: design and evaluation of an educational World Wide Web site. Med Inform Internet Med. 2000 Jul-Sep;25(3):195-206. doi: 10.1080/146392300750019190.
Resnic FS, Popma JJ, Ohno-Machado L. Development and evaluation of models to predict death and myocardial infarction following coronary angioplasty and stenting. Proc AMIA Symp. 2000:690-3.
Gibson CM. A union in reperfusion: the concept of facilitated percutaneous coronary intervention. J Am Coll Cardiol. 2000 Nov 1;36(5):1497-9. doi: 10.1016/s0735-1097(00)00926-8.
de Lemos JA, Antman EM, Giugliano RP, McCabe CH, Murphy SA, Van de Werf F, Gibson CM, Braunwald E. ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigators. Am J Cardiol. 2000 Feb 1;85(3):299-304. doi: 10.1016/s0002-9149(99)00736-5.
Michaels AD, Gibson CM, Barron HV. Microvascular dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon. Am J Cardiol. 2000 Mar 9;85(5A):50B-60B. doi: 10.1016/s0002-9149(00)00811-0.
Dotani MI, Elnicki DM, Jain AC, Gibson CM. Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Am J Cardiol. 2000 Nov 15;86(10):1128-30, A6. doi: 10.1016/s0002-9149(00)01172-3.
Festa A, D’Agostino R Jr, Rautaharju P, Mykkänen L, Haffner SM. Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects. Am J Cardiol. 2000 Nov 15;86(10):1117-22. doi: 10.1016/s0002-9149(00)01170-x.
Antman EM, Gibson CM, de Lemos JA, Giugliano RP, McCabe CH, Coussement P, Menown I, Nienaber CA, Rehders TC, Frey MJ, Van der Wieken R, Andresen D, Scherer J, Anderson K, Van de Werf F, Braunwald E. Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators. Eur Heart J. 2000 Dec;21(23):1944-53. doi: 10.1053/euhj.2000.2243.
Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson CM. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation. 2000 Nov 7;102(19):2329-34. doi: 10.1161/01.cir.102.19.2329.
Braunwald E, Califf RM, Cannon CP, Fox KA, Fuster V, Gibler WB, Harrington RA, King SB 3rd, Kleiman NS, Theroux P, Topol EJ, Van de Werf F, White HD, Willerson JT. Redefining medical treatment in the management of unstable angina. Am J Med. 2000 Jan;108(1):41-53. doi: 10.1016/s0002-9343(99)00416-7.
Cannon CP. Multimodality reperfusion therapy for acute myocardial infarction. Am Heart J. 2000 Nov;140(5):707-16. doi: 10.1067/mhj.2000.110289.
Cannon CP, Sayah AJ, Walls RM. ER TIMI-19: testing the reality of prehospital thrombolysis. J Emerg Med. 2000 Oct;19(3 Suppl):21S-25S. doi: 10.1016/s0736-4679(00)00251-1.
Zimetbaum PJ, Josephson ME, McDonald MJ, McClennen S, Korley V, Ho KK, Papageorgiou P, Cohen DJ. Incidence and predictors of myocardial infarction among patients with atrial fibrillation. J Am Coll Cardiol. 2000 Oct;36(4):1223-7. doi: 10.1016/s0735-1097(00)00828-7.
Cantor WJ, Peterson ED, Popma JJ, Zidar JP, Sketch MH Jr, Tcheng JE, Ohman EM. Provisional stenting strategies: systematic overview and implications for clinical decision-making. J Am Coll Cardiol. 2000 Oct;36(4):1142-51. doi: 10.1016/s0735-1097(00)00854-8.
Fang JC, Kinlay S, Wexberg P, Amirzadeh A, Gibson CM, Selwyn AP, Ganz P. Use of the thrombolysis in myocardial infarction frame count for the quantitative assessment of transplant-associated arteriosclerosis. Am J Cardiol. 2000 Oct 15;86(8):890-2. doi: 10.1016/s0002-9149(00)01115-2.
Popma JJ, Sawyer M, Selwyn AP, Kinlay S. Lipid-lowering therapy after coronary revascularization. Am J Cardiol. 2000 Aug 24;86(4B):18H-28H. doi: 10.1016/s0002-9149(00)01096-1.
Orford JL, Selwyn AP, Ganz P, Popma JJ, Rogers C. The comparative pathobiology of atherosclerosis and restenosis. Am J Cardiol. 2000 Aug 24;86(4B):6H-11H. doi: 10.1016/s0002-9149(00)01094-8.
Januzzi JL, Hahn SS, Chae CU, Giugliano R, Lewandrowski K, Theroux P, Jang IK. Effects of tirofiban plus heparin versus heparin alone on troponin I levels in patients with acute coronary syndromes. Am J Cardiol. 2000 Oct 1;86(7):713-7. doi: 10.1016/s0002-9149(00)01068-7.
Stec JJ, Silbershatz H, Tofler GH, Matheney TH, Sutherland P, Lipinska I, Massaro JM, Wilson PF, Muller JE, D’Agostino RB Sr. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation. 2000 Oct 3;102(14):1634-8. doi: 10.1161/01.cir.102.14.1634.
Festa A, D’Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int. 2000 Oct;58(4):1703-10. doi: 10.1046/j.1523-1755.2000.00331.x.
McClennen S, Zimetbaum PJ, Ho KK, Goldberger AL. Holter monitoring: are two days better than one?. Am J Cardiol. 2000 Sep 1;86(5):562-4, A9. doi: 10.1016/s0002-9149(00)01017-1.
Azar RR, Prpic R, Ho KK, Kiernan FJ, Shubrooks SJ Jr, Baim DS, Popma JJ, Kuntz RE, Cohen DJ. Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol. 2000 Sep 1;86(5):485-9. doi: 10.1016/s0002-9149(00)00998-x.
Taira DA, Seto TB, Ho KK, Krumholz HM, Cutlip DE, Berezin R, Kuntz RE, Cohen DJ. Impact of smoking on health-related quality of life after percutaneous coronary revascularization. Circulation. 2000 Sep 19;102(12):1369-74. doi: 10.1161/01.cir.102.12.1369.
Lansky AJ, Roubin GS, O’Shaughnessy CD, Moore PB, Dean LS, Raizner AE, Safian RD, Zidar JP, Kerr JL, Popma JJ, Mehran R, Kuntz RE, Leon MB. Randomized comparison of GR-II stent and Palmaz-Schatz stent for elective treatment of coronary stenoses. Circulation. 2000 Sep 19;102(12):1364-8. doi: 10.1161/01.cir.102.12.1364.
Kornowski R, Baim DS, Moses JW, Hong MK, Laham RJ, Fuchs S, Hendel RC, Wallace D, Cohen DJ, Bonow RO, Kuntz RE, Leon MB. Short- and intermediate-term clinical outcomes from direct myocardial laser revascularization guided by biosense left ventricular electromechanical mapping. Circulation. 2000 Sep 5;102(10):1120-5. doi: 10.1161/01.cir.102.10.1120.
Klingenheben T, Zabel M, D’Agostino RB, Cohen RJ, Hohnloser SH. Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet. 2000 Aug 19;356(9230):651-2. doi: 10.1016/s0140-6736(00)02609-x.
Taborelli G, Melagrana A, D’Agostino R, Tarantino V, Calveo MG, Calevo. Vestibular neuronitis in children: study of medium and long term follow-up. Int J Pediatr Otorhinolaryngol. 2000 Aug 31;54(2-3):117-21. doi: 10.1016/s0165-5876(00)00358-x.
Saucedo JF, Popma JJ, Kennard ED, Talley JD, Lansky A, Leon MB, Baim DS. Relation of coronary artery size to one-year clinical events after new device angioplasty of native coronary arteries (a New Approach to Coronary Intervention [NACI] Registry Report). Am J Cardiol. 2000 Jan 15;85(2):166-71. doi: 10.1016/s0002-9149(99)00649-9.
Cutlip DE. Stent thrombosis: historical perspectives and current trends. J Thromb Thrombolysis. 2000 Aug;10(1):89-101. doi: 10.1023/a:1018763108106.
Kereiakes D, Linnemeier TJ, Baim DS, Kuntz R, O’Shaughnessy C, Hermiller J, Fink S, Lansky A, Nishimura N, Broderick TM, Popma J. Usefulness of stent length in predicting in-stent restenosis (the MULTI-LINK stent trials). Am J Cardiol. 2000 Aug 1;86(3):336-41. doi: 10.1016/s0002-9149(00)00928-0.
Fitzgerald PJ, Oshima A, Hayase M, Metz JA, Bailey SR, Baim DS, Cleman MW, Deutsch E, Diver DJ, Leon MB, Moses JW, Oesterle SN, Overlie PA, Pepine CJ, Safian RD, Shani J, Simonton CA, Smalling RW, Teirstein PS, Zidar JP, Yeung AC, Kuntz RE, Yock PG. Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation. 2000 Aug 1;102(5):523-30. doi: 10.1161/01.cir.102.5.523.
Cannon CP, McCabe CH, Wilcox RG, Langer A, Caspi A, Berink P, Lopez-Sendon J, Toman J, Charlesworth A, Anders RJ, Alexander JC, Skene A, Braunwald E. Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. Circulation. 2000 Jul 11;102(2):149-56. doi: 10.1161/01.cir.102.2.149.
Januzzi JL Jr, Stern TA, Pasternak RC, DeSanctis RW. The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med. 2000 Jul 10;160(13):1913-21. doi: 10.1001/archinte.160.13.1913.
Festa A, D’Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000 Jul 4;102(1):42-7. doi: 10.1161/01.cir.102.1.42.
Dauerman HL, Prpic R, Andreou C, Vu MA, Popma JJ. Angiographic and clinical outcomes after rescue coronary stenting. Catheter Cardiovasc Interv. 2000 Jul;50(3):269-75. doi: 10.1002/1522-726x(200007)50:3<269::aid-ccd1>3.0.co;2-k.
de Lemos JA, Antman EM, Morrow DA, Llevadot J, Giugliano RP, Coulter SA, Schuhwerk KC, Arslanian S, McCabe CH, Gibson CM, Rifai N. Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy. Clin Chim Acta. 2000 Aug;298(1-2):85-97. doi: 10.1016/s0009-8981(00)00259-x.
Elias MF, Beiser A, Wolf PA, Au R, White RF, D’Agostino RB. The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol. 2000 Jun;57(6):808-13. doi: 10.1001/archneur.57.6.808.
Turchin A, Radentz SS, Burke A. Situs inversus totalis and single coronary ostium: A coincidence or a pattern?. Cardiovasc Pathol. 2000 Mar-Apr;9(2):127-9. doi: 10.1016/s1054-8807(99)00040-x.
Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ, Gore JM, Weaver WD, Rogers WJ, Tiefenbrunn AJ. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000 Jun 14;283(22):2941-7. doi: 10.1001/jama.283.22.2941.
Seto TB, Taira DA, Berezin R, Chauhan MS, Cutlip DE, Ho KK, Kuntz RE, Cohen DJ. Percutaneous coronary revascularization in elderly patients: impact on functional status and quality of life. Ann Intern Med. 2000 Jun 20;132(12):955-8. doi: 10.7326/0003-4819-132-12-200006200-00005.
Llevadot J, Giugliano RP, McCabe CH, Cannon CP, Antman EM, Murphy S, Gibson CM. Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis In Myocardial Infarction [TIMI] trials). Am J Cardiol. 2000 Jun 15;85(12):1409-13. doi: 10.1016/s0002-9149(00)00786-4.
Coulter SA, Cannon CP, Ault KA, Antman EM, Van de Werf F, Adgey AA, Gibson CM, Giugliano RP, Mascelli MA, Scherer J, Barnathan ES, Braunwald E, Kleiman NS. High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14. Circulation. 2000 Jun 13;101(23):2690-5. doi: 10.1161/01.cir.101.23.2690.
Beiser A, D’Agostino RB Sr, Seshadri S, Sullivan LM, Wolf PA. Computing estimates of incidence, including lifetime risk: Alzheimer’s disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Stat Med. 2000 Jun 15-30;19(11-12):1495-522. doi: 10.1002/(sici)1097-0258(20000615/30)19:11/12<1495::aid-sim441>3.0.co;2-e.
Festa A, D’Agostino R Jr, Hales CN, Mykkänen L, Haffner SM. Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects. Diabetes Care. 2000 May;23(5):624-8. doi: 10.2337/diacare.23.5.624.
Wilensky RL, Tanguay JF, Ito S, Bartorelli AL, Moses J, Williams DO, Bailey SR, Martin J, Bucher TA, Gallant P, Greenberg A, Popma JJ, Weissman NJ, Mintz GS, Kaplan AV, Leon MB. Heparin infusion prior to stenting (HIPS) trial: final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia. Am Heart J. 2000 Jun;139(6):1061-70. doi: 10.1067/mhj.2000.106614.
Ettenson DS, Koo EW, Januzzi JL, Edelman ER. Endothelial heparan sulfate is necessary but not sufficient for control of vascular smooth muscle cell growth. J Cell Physiol. 2000 Jul;184(1):93-100. doi: 10.1002/(SICI)1097-4652(200007)184:1<93::AID-JCP10>3.0.CO;2-H.
Saucedo JF, Kennard ED, Popma JJ, Talley D, Lansky A, Leon MB, Baim DS. Importance of lesion length on new device angioplasty of native coronary arteries. NACI Investigators. New Approaches to Coronary Interventions. Catheter Cardiovasc Interv. 2000 May;50(1):19-25. doi: 10.1002/(sici)1522-726x(200005)50:1<19::aid-ccd4>3.0.co;2-h.
Baim DS. Is it time to offer elective percutaneous treatment of the unprotected left main coronary artery?. J Am Coll Cardiol. 2000 May;35(6):1551-3. doi: 10.1016/s0735-1097(00)00598-2.
Modi NB, Fox NL, Clow FW, Tanswell P, Cannon CP, Van de Werf F, Braunwald E. Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarction. J Clin Pharmacol. 2000 May;40(5):508-15. doi: 10.1177/00912700022009125.
Fraenkel L, Tofler GH, Zhang Y, Silbershatz H, D’Agostino RB, Wilson PW, Felson DT. The associations between plasma levels of von Willebrand factor and fibrinogen with Raynaud’s phenomenon in men and women. Am J Med. 2000 May;108(7):583-6. doi: 10.1016/s0002-9343(00)00350-8.
Dauerman HL, Prpic R, Andreou C, Popma JJ. Resolution of coronary thrombus with rescue stenting. Am J Cardiol. 2000 May 15;85(10):1244-7. doi: 10.1016/s0002-9149(00)00737-2.
Davidson CJ, Laskey WK, Hermiller JB, Harrison JK, Matthai W Jr, Vlietstra RE, Brinker JA, Kereiakes DJ, Muhlestein JB, Lansky A, Popma JJ, Buchbinder M, Hirshfeld JW Jr. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial. Circulation. 2000 May 9;101(18):2172-7. doi: 10.1161/01.cir.101.18.2172.
Kuntz RE, Baim DS. Prevention of coronary restenosis : the evolving evidence base for radiation therapy. Circulation. 2000 May 9;101(18):2130-3. doi: 10.1161/01.cir.101.18.2130.
Cannon CP. Thrombolysis medication errors: benefits of bolus thrombolytic agents. Am J Cardiol. 2000 Apr 27;85(8A):17C-22C. doi: 10.1016/s0002-9149(00)00874-2.
Moore LL, Visioni AJ, Wilson PW, D’Agostino RB, Finkle WD, Ellison RC. Can sustained weight loss in overweight individuals reduce the risk of diabetes mellitus?. Epidemiology. 2000 May;11(3):269-73. doi: 10.1097/00001648-200005000-00007.
Zalenski RJ, Selker HP, Cannon CP, Farin HM, Gibler WB, Goldberg RJ, Lambrew CT, Ornato JP, Rydman RJ, Steele P. National Heart Attack Alert Program position paper: chest pain centers and programs for the evaluation of acute cardiac ischemia. Ann Emerg Med. 2000 May;35(5):462-71.
Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D’Agostino R Jr. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000 Apr-Jun;26(2):191-208. doi: 10.1080/009262300278597.
Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D’Agostino RB, Newman AB, Lebowitz MD, Pickering TG. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000 Apr 12;283(14):1829-36. doi: 10.1001/jama.283.14.1829.
Wang JC, Goldhaber SZ, Popma JJ. Use of enoxaparin in a patient with unstable angina. J Invasive Cardiol. 2000;12 Suppl C:18C-20C.
Baim DS, Knopf WD, Hinohara T, Schwarten DE, Schatz RA, Pinkerton CA, Cutlip DE, Fitzpatrick M, Ho KK, Kuntz RE. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND II) trials. Am J Cardiol. 2000 Apr 1;85(7):864-9. doi: 10.1016/s0002-9149(99)00882-6.
D’Agostino RB Sr. Controlling alpha in a clinical trial: the case for secondary endpoints. Stat Med. 2000 Mar 30;19(6):763-6. doi: 10.1002/(sici)1097-0258(20000330)19:6<763::aid-sim517>3.0.co;2-8.
Holmes MB, Sobel BE, Cannon CP, Schneider DJ. Increased platelet reactivity in patients given orbofiban after an acute coronary syndrome: an OPUS-TIMI 16 substudy. Orbofiban in Patients with Unstable coronary syndromes. Thrombolysis In Myocardial Infarction. Am J Cardiol. 2000 Feb 15;85(4):491-3, A10. doi: 10.1016/s0002-9149(99)00778-x.
Cannon CP. Bridging the gap with new strategies in acute ST elevation myocardial infarction: bolus thrombolysis, glycoprotein IIb/IIIa inhibitors, combination therapy, percutaneous coronary intervention, and “facilitated” PCI. J Thromb Thrombolysis. 2000 Apr;9(3):235-41. doi: 10.1023/a:1018714627681.
Bruce CJ, Kuntz RE, Popma JJ, Pieper KS, Topol EJ, Holmes DR Jr. Application of a continuous regression model of restenosis to saphenous vein grafts after successful percutaneous transluminal coronary angioplasty or directional coronary atherectomy. J Am Coll Cardiol. 2000 Mar 1;35(3):619-23. doi: 10.1016/s0735-1097(99)00595-1.
Lehmann KG, Popma JJ, Werner JA, Lansky AJ, Wilensky RL. Vascular remodeling and the local delivery of cytochalasin B after coronary angioplasty in humans. J Am Coll Cardiol. 2000 Mar 1;35(3):583-91. doi: 10.1016/s0735-1097(99)00603-8.
Gates GA, Schmid P, Kujawa SG, Nam B, D’Agostino R. Longitudinal threshold changes in older men with audiometric notches. Hear Res. 2000 Mar;141(1-2):220-8. doi: 10.1016/s0378-5955(99)00223-3.
Dauerman HL, Pinto DS, Ho KK, Gibson CM, Kuntz RE, Cohen DJ, Baim DS, Carrozza JP Jr. Outcome of patients with acute myocardial infarction who are ineligible for primary angioplasty trials. Catheter Cardiovasc Interv. 2000 Mar;49(3):237-43. doi: 10.1002/(sici)1522-726x(200003)49:3<237::aid-ccd1>3.0.co;2-7.
Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald E. Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. J Am Coll Cardiol. 2000 Feb;35(2):358-62. doi: 10.1016/s0735-1097(99)00574-4.
Feng D, Tofler GH, Larson MG, O’Donnell CJ, Lipinska I, Schmitz C, Sutherland PA, Johnstone MT, Muller JE, D’Agostino RB, Levy D, Lindpaintner K. Factor VII gene polymorphism, factor VII levels, and prevalent cardiovascular disease: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2000 Feb;20(2):593-600. doi: 10.1161/01.atv.20.2.593.
Every NR, Hochman J, Becker R, Kopecky S, Cannon CP. Critical pathways : a review. Committee on Acute Cardiac Care, Council on Clinical Cardiology, American Heart Association. Circulation. 2000 Feb 1;101(4):461-5. doi: 10.1161/01.cir.101.4.461.
Teirstein PS, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Sirkin K, Cloutier DA, Leon MB, Tripuraneni P. Three-year clinical and angiographic follow-up after intracoronary radiation : results of a randomized clinical trial. Circulation. 2000 Feb 1;101(4):360-5. doi: 10.1161/01.cir.101.4.360.
Cannon CP. Defining acute myocardial infarction by ST segment deviation. Eur Heart J. 2000 Feb;21(4):266-7. doi: 10.1053/euhj.1999.1921.
D’Agostino RB, Russell MW, Huse DM, Ellison RC, Silbershatz H, Wilson PW, Hartz SC. Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J. 2000 Feb;139(2 Pt 1):272-81. doi: 10.1067/mhj.2000.96469.
Peterson ED, Lansky AJ, Anstrom KJ, Muhlbaier LH, Popma JJ, Satler LF, Lanzilotta MJ. Evolving trends in interventional device use and outcomes: results from the National Cardiovascular Network Database. Am Heart J. 2000 Feb;139(2 Pt 1):198-207. doi: 10.1067/mhj.2000.103848.
von Birgelen C, Mintz GS, de Vrey EA, Serruys PW, Kimura T, Nobuyoshi M, Popma JJ, Leon MB, Erbel R, de Feyter PJ. Preintervention lesion remodelling affects operative mechanisms of balloon optimised directional coronary atherectomy procedures: a volumetric study with three dimensional intravascular ultrasound. Heart. 2000 Feb;83(2):192-7. doi: 10.1136/heart.83.2.192.
Poli KA, Tofler GH, Larson MG, Evans JC, Sutherland PA, Lipinska I, Mittleman MA, Muller JE, D’Agostino RB, Wilson PW, Levy D. Association of blood pressure with fibrinolytic potential in the Framingham offspring population. Circulation. 2000 Jan 25;101(3):264-9. doi: 10.1161/01.cir.101.3.264.
de Lemos JA, Antman EM, Gibson CM, McCabe CH, Giugliano RP, Murphy SA, Coulter SA, Anderson K, Scherer J, Frey MJ, Van Der Wieken R, Van De Werf F, Braunwald E. Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial. Circulation. 2000 Jan 25;101(3):239-43. doi: 10.1161/01.cir.101.3.239.
Gibson CM, Cannon CP, Murphy SA, Ryan KA, Mesley R, Marble SJ, McCabe CH, Van De Werf F, Braunwald E. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation. 2000 Jan 18;101(2):125-30. doi: 10.1161/01.cir.101.2.125.
Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, Lipinska I, D’Agostino RB, Wilson PW. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA. 2000 Jan 12;283(2):221-8. doi: 10.1001/jama.283.2.221.
Gibson CM, Mallett TC, Claiborne A, Caparon MG. Contribution of NADH oxidase to aerobic metabolism of Streptococcus pyogenes. J Bacteriol. 2000 Jan;182(2):448-55. doi: 10.1128/jb.182.2.448-455.2000.
Grundy SM, Bazzarre T, Cleeman J, D’Agostino RB Sr, Hill M, Houston-Miller N, Kannel WB, Krauss R, Krumholz HM, Lauer RM, Ockene IS, Pasternak RC, Pearson T, Ridker PM, Wood D. Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I. Circulation. 2000 Jan 4;101(1):E3-E11. doi: 10.1161/01.cir.101.1.e3.
Goel M, Marble SJ, Gibson CM. Key references on a wide variety of topics pertaining to coronary artery blood flow and patency. J Thromb Thrombolysis. 2000 Jan;9(1):85-93. doi: 10.1023/a:1018621525593.